SCHEMBL980746

SCHEMBL980746

CN(C)CCCc1[c]cccc1CC(=O)N1CCC(c2cc(F)ccc2F)=N1

nearest known ligand 0.42

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 20/20 0.42
KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL982312 0.88 MAOB (0.39) KIF11KCNH2
SCHEMBL980138 0.87 HCRTR1 (0.35) KIF11
SCHEMBL981265 0.85 KIF11 (0.45) KIF11
SCHEMBL980074 0.85 MET (0.44)
SCHEMBL5046577 0.73 KIF11 (0.40) KIF11KCNH2
SCHEMBL980244 0.72 MAOA (0.40) KIF11
SCHEMBL979241 0.72 MET (0.40) KIF11KCNH2
SCHEMBL28661764 0.67 KIF11 (0.46) KIF11KCNH2
SCHEMBL980246 0.66 KIF11 (0.34) KIF11KCNH2
SCHEMBL17004383 0.66 MET (0.49) KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7875644-B2 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas MERCK PATENT GMBH (DE) 2011-01-25 US claimed